Dang et al. [5] showed that in IDH1-mutated gliomas the concentrations of (R)-2-hydroxyglutarate determined by LC–MS analysis could go up to tens of μmol/g, which would be also NMR-detectable. The gene discussed is IDH1; the disease is central nervous system cancer.